Navigation Links
LA BioMed investigator wins Distinguished Educator Award
Date:6/10/2008

TORRANCE (June 10, 2008) The Endocrine Society will present Ronald S. Swerdloff, M.D., a chief investigator at Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center (LA BioMed), with its Distinguished Educator Award during its annual convention June 15-18 in San Francisco.

The Endocrine Society, an international association of 13,000 members representing the full range of disciplines associated with endocrinology, bestows this honor to a single recipient "in recognition of exceptional achievement as an educator in the discipline of endocrinology and metabolism."

Dr. Swerdloff has been teaching for 39 years. For 35 of those years, he directed the clinical and research training programs at Harbor-UCLA Medical Center, training more than 130 endocrine fellows.

"Dr. Swerdloff is a highly accomplished educator, scientist, administrator and clinician," said The Endocrine Society President Margaret A. Shupnik, Ph.D. "His educational leadership has created a legacy of outstanding trainees who have followed his example as a role model and added their own outstanding contributions to the field of reproductive endocrinology."

In addition to his work at LA BioMed, Dr. Swerdloff is a professor of medicine at UCLA's David Geffen School of Medicine, and he is the chief of Harbor-UCLA Medical Center's Division of Endocrinology. He has received numerous previous awards, including the Distinguished Andrologist Award from the American Society of Andrology, The Most Outstanding Faculty Award at UCLA and the Outstanding West Coast Investigator from the Western Society of Clinical Investigation.

Dr. Swerdloff has served in leadership roles for many regional and national societies, including the American Society of Andrology (President) and The Endocrine Society (Associate Editor, the Journal of Clinical Endocrinology and Metabolism).

He was a long-time member of the Methods for Regulation of Fertility tas
'/>"/>

Contact: Laura Mecoy
LMecoy@issuesmanagement.com
310-546-5860
Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center (LA BioMed)
Source:Eurekalert  

0

GOOD

Page: 1 2

Related medicine news :

1. Response Biomedical appoints S. Wayne Kay Chief Executive Officer
2. Biomedtex Inc. Announces A. Marc Rocca as President and CEO
3. Hopes, Predictions and Realities: Is Biomedical Research Delivering On Its Promises?
4. Dr. Andrew K. Palmer Joins BMEs (BioMedical Enterprises, Inc.) Board of Directors
5. BioMed Realty Trust to Report 2007 Third Quarter Results
6. BME (BioMedical Enterprises, Inc.) Announces U.S. Launch of the OSSArc(TM) Anatomic Residual Compression Implant
7. Response Biomedical Corporation Receives Conditional Listing Approval from the Toronto Stock Exchange
8. BioMed Realty Trust Reports Third Quarter 2007 Financial Results
9. LA BioMed research finds simpler way to assess breast cancer risk
10. LA BioMed researchers find few emergency rooms fully equipped for pediatric patients
11. BioMed Realty Trust Declares Fourth Quarter 2007 Common Stock and Preferred Stock Dividends

Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
LA BioMed investigator wins Distinguished Educator Award
LA BioMed investigator wins Distinguished Educator Award
(Date:11/21/2009)... for an unprecedented expansion of federally-funde... for preserving and protecting human life? If the ...ine Yoest ,, WASHINGTON, Nov. 21 /PRNewswire-...esident and CEO Dr. Charmaine Yoest responded to t...wing statement: ,, "This was a pro-abortion vo...
(Date:11/21/2009)...medical credentialing software company IntelliSoft...nerhsip with Amerinet, Inc., the leading healthcar...o transform quality care within the healthcare mar...1, 2009 -- ISG Group, LLC, doing business as Intel...merinet Inc., a leading national healthcare group ...
(Date:11/21/2009)...roup ask whether there is a secret to ,alcohol reh... London, UK (PRWEB) November 21, 2009 ...ee of the adult UK population drinking enough alco... liver disease*, it is hardly a surprise that many...mmes and residential centres for help. However, fo...
(Date:11/20/2009)...PRNewswire/ -- Following a recall by Unilever The ...ale Shedd,s Country Crock ® Side Dishes DELUX...® Side Dishes DELUXE Four Cheese Pasta due to...ing code dates and UPCs are affected: ,, Shedd... Broccoli Rice 21 oz, UPC 027400218316, Best By NO...
(Date:11/20/2009)...vember 20 Cardio Vascula...MEDICAL.COM , a leading,developer of advanced card...t,the company,s Board of Directors has decided to ... the Far East for its proprietary next-generation,...ty (PCTA) procedures. , Cardio Vascular M...
Breaking Medicine News(10 mins):Health News:Leading Anti-Abortion Group Vows to Vigorously Fight the Senate Health Bill 2Health News:IntelliSoft Group and Amerinet Inc. Form Partnership to Transform Healthcare Delivery of Quality Patient Safety and Care 2Health News:Linwood Group Reveal How to Decide whether Alcohol Rehab Centres are a Success or Not 2Health News:Linwood Group Reveal How to Decide whether Alcohol Rehab Centres are a Success or Not 3Health News:Linwood Group Reveal How to Decide whether Alcohol Rehab Centres are a Success or Not 4Health News:Stop & Shop Alerts Customers to Voluntary Recall by Unilever 2Health News:Cardio Vascular Medical Device to Apply for Additional Patents in Europe, Canada and Far East 2
... National Center for Sports Safety (NCSS) and the ...e finalized a partnership to educate Mississippi,s... of sports safety. , , The MHSAA executive commit... this tool a permanent part of every school,s athl...
...y regimen to individuals, experts say , , ...tions appear to affect the way children respond to... report. , Although about 80 percent of children s...For the first time, we used a genome-wide strategy...
...or earlier screening, study notes, , , TUE...emale childhood cancer survivors under the age of ...ent are not following the recommended advice to ge...after the last radiation treatment, whichever come...
...gagementHealth, LLC., an innovator in corporate we...unch of its comprehensive disease prevention and h...p. (Nasdaq: RBNF ). Rurban Financial is a leadin...o. EngagementHealth(R) offers to all Rurban Financ...
...central pharmacy automation solutions , , MOUNTAI... OMCL ) a leading provider of system solutions to...ive year, sole-source contract by Emory Healthcare...of systems targeting patient safety and operationa...
...Environmental Tobacco Smoke (ETS) commonly called ...may account for complications during pregnancy and... more adverse pregnancy effects than do whites fro...ther black, non-smoking women were able to avoid E...
Other Medicine News:Health News:National Center for Sports Safety Teams With Mississippi to Train State's High School Coaches 2Health News:In Kids, Genes May Affect Leukemia Treatment 2Health News:In Kids, Genes May Affect Leukemia Treatment 3Health News:Childhood Cancer Survivors Not Getting Recommended Mammograms 2Health News:Childhood Cancer Survivors Not Getting Recommended Mammograms 3Health News:EngagementHealth(R) Launches Comprehensive Wellness Programs With Rurban Financial Corp. (Nasdaq - RBNF) 2Health News:Avoiding secondhand smoke during pregnancy 2
(Date:11/20/2009)... 20 Soligenix, Inc. (OTC... formerly known as DOR BioPharma, Inc., a late-sta...has formed a consortium to develop thermostable te...ting vaccines. Soligenix received a $9.4 million g...fectious Diseases (NIAID), a division of the Natio...
(Date:11/19/2009)...PRNewswire/ -- In response to an ever-increasing n...medicines, Operation Pangea II, involving 24 count...alth Organization,s International Medical Products...ht the dangers of buying medicines online. ,, T...s of arrests and the seizure of thousands of poten...
(Date:11/19/2009)...Nov. 19 Alexza Pharmaceu... its corporate presentation will be webcast live d...nference on Wednesday, December 2, 2009 at 9:00 a.... from The New York Palace Hotel in New York and wi...t and CEO. ,, To access the live presentation...
Breaking Medicine Technology:Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 2Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 3Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 4Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 5Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 6International Operation Combats Online Supply of Counterfeit and Illegal Medicines 2Alexza Pharmaceuticals to Present at the 21st Annual Piper Jaffray Health Care Conference 2Alexza Pharmaceuticals to Present at the 21st Annual Piper Jaffray Health Care Conference 3Quark Pharmaceuticals to Participate in IBCs Oligonucleotide Therapeutics 3A From Concept to Implementation Conference 53480 1Quark Pharmaceuticals to Participate in IBCs Oligonucleotide Therapeutics 3A From Concept to Implementation Conference 53480 2Quark Pharmaceuticals to Participate in IBCs Oligonucleotide Therapeutics 3A From Concept to Implementation Conference 53480 3Keryx Biopharmaceuticals Announces Agreement with FDA on a Special Protocol Assessment for Phase 3 Trial of KRX 0401 28Perifosine 29 in the Treatment 53476 1Keryx Biopharmaceuticals Announces Agreement with FDA on a Special Protocol Assessment for Phase 3 Trial of KRX 0401 28Perifosine 29 in the Treatment 53476 2Keryx Biopharmaceuticals Announces Agreement with FDA on a Special Protocol Assessment for Phase 3 Trial of KRX 0401 28Perifosine 29 in the Treatment 53476 3Keryx Biopharmaceuticals Announces Agreement with FDA on a Special Protocol Assessment for Phase 3 Trial of KRX 0401 28Perifosine 29 in the Treatment 53476 4Keryx Biopharmaceuticals Announces Agreement with FDA on a Special Protocol Assessment for Phase 3 Trial of KRX 0401 28Perifosine 29 in the Treatment 53476 5Oncothyreon announces presentation of long term Stimuvax data at World Conference on Lung Cancer 13328 1Oncothyreon announces presentation of long term Stimuvax data at World Conference on Lung Cancer 13328 2Oncothyreon announces presentation of long term Stimuvax data at World Conference on Lung Cancer 13328 3Oncothyreon announces presentation of long term Stimuvax data at World Conference on Lung Cancer 13328 4
...oratory and a worldwide leader in innovative labor...ensive test menu of highly complex and unique medi...d by the University of Utah, ARUP Laboratories' cl...rsity teaching hospitals and children's hospitals,...
...oratory and a worldwide leader in innovative labor...ensive test menu of highly complex and unique medi...d by the University of Utah, ARUP Laboratories' cl...rsity teaching hospitals and children's hospitals,...
...oratory and a worldwide leader in innovative labor...ensive test menu of highly complex and unique medi...d by the University of Utah, ARUP Laboratories' cl...rsity teaching hospitals and children's hospitals,...
...oratory and a worldwide leader in innovative labor...ensive test menu of highly complex and unique medi...d by the University of Utah, ARUP Laboratories' cl...rsity teaching hospitals and children's hospitals,...
Medicine Products: